Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP   3:59:54 PM EDT
0.67
+0.02 (+3.00%)
Other Pre-Announcement

Tonix Pharma Enrolls First Participant To Study Development Of Precision Medicine Techniques

Published: 10/15/2020 11:40 GMT
Tonix Pharmaceuticals Holding Corp (TNXP) - Tonix Pharmaceuticals Enrolls First Participant in the Precision Study, an Observational Study to Facilitate Development of Precision Medicine Techniques for Covid-19 Vaccines and Therapeutics.
Tonix Pharmaceuticals Holding Corp - Results From Precision Study Expected in First Half of 2021.
Tonix Pharmaceuticals Holding Corp - Study May Lead to Biomarkers for Tailoring Covid-19 Vaccines and Therapeutics.